HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.

AuthorsHoury Leblebjian, Kimberly Noonan, Claudia Paba-Prada, Steven P Treon, Jorge J Castillo, Irene M Ghobrial
JournalAmerican journal of hematology (Am J Hematol) Vol. 90 Issue 6 Pg. E122-3 (Jun 2015) ISSN: 1096-8652 [Electronic] United States
PMID25703132 (Publication Type: Letter)
Chemical References
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
  • Cyclophosphamide
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Boronic Acids (administration & dosage)
  • Bortezomib
  • Cyclophosphamide (administration & dosage)
  • Dexamethasone (administration & dosage)
  • Female
  • Humans
  • Male
  • Pyrazines (administration & dosage)
  • Retrospective Studies
  • Waldenstrom Macroglobulinemia (drug therapy, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: